A

Alexion

Global biopharmaceuticals focusing on rare diseases

Senior Manager – Rare Endo & Rare Tumors Marketing Operations Lead

Growth & MarketingPosted on Nov 9
Full-timeBoston, MA, USAIn-person

About the Job

Requirements

  • A bachelor's degree in a relevant field is required.
  • At least 3 years of marketing or sales experience in biopharma is required.
  • Proven leadership and communication skills and the ability to collaborate in a matrix environment are required.
  • Demonstrated success managing multiple projects across functions and working independently, in teams, and as a sub-team lead is required.
  • Learning agility and comfort working in a fast-paced environment are required.
  • Experience managing external agencies and/or vendors day to day and managing budgets is required.
  • Strong interpersonal skills and written and verbal communication skills are required.
  • Strong knowledge of Microsoft Word, PowerPoint, and Excel is required.
  • The role is generally conducted in an office environment and requires the ability, with or without accommodation, to use a computer; communicate by phone, video, and electronic messaging; problem-solve; engage in complex and non-linear thought, analysis, and dialogue; collaborate with others; and maintain general availability during standard business hours.

Responsibilities

  • Coordinate deliverables for national conferences and ensure timely approval, production, and delivery in collaboration with marketing and the congress planning team.
  • Ensure accurate submission and reporting, including approvals and close-outs, for national conferences and health care professional and patient engagement opportunities.
  • Manage relationships with external print and fulfillment vendors to maintain sufficient inventory, ensure efficient and timely production and delivery, and meet spending targets within the annual budget.
  • Maintain ordering portal quality control so the field has access to current materials and resources.
  • Liaise with the sales team regarding field material requests for day-to-day needs and regional congress events.
  • Manage Veeva CRM and Veeva Vault operations, including content deployment, field resource availability, materials utilization reporting, and support for content approval and distribution processes.
  • Lead planning, coordination, and execution of field material rollouts, campaign launches, and launch readiness activities supporting business priorities and strategic initiatives.
  • Support marketing teams with logistical needs for key cross-functional meetings, including attendee, room, and communication coordination.
  • Oversee development and updates of sales force resource guides and track utilization of sales force resources in inventory.
  • Collaborate with Procurement and Legal to process and submit contractual documents, including master service agreements.
  • Partner with Finance to oversee purchase order submission and creation, and budget and accrual tracking for the Rare Endocrinology and Rare Tumor Marketing teams.
  • Collaborate with cross-functional teams, including therapeutic area leadership, executive and regional sales directors, Commercial Operations, Sales Operations, Medical, Regulatory Affairs, Legal, and Compliance, to coordinate execution across roles and responsibilities.

Desired Qualifications

  • Rare disease or oncology experience is preferred.
  • A track record of developing and implementing marketing strategies and tactics that delivered strong commercial results is preferred.
  • A strong scientific orientation and background are preferred.
  • Experience launching or working with a newly launched product and/or global experience is preferred.
  • Prior experience in health care agency or consultancy roles is preferred.

About the Company

Alexion

Global biopharmaceuticals focusing on rare diseases

Alexion, now the rare disease group within AstraZeneca, develops and sells therapies for rare and ultra-rare diseases by targeting the complement immune system. Its drugs, such as Soliris and Ultomiris, inhibit the C5 component to slow or stop disease processes, while Strensiq and Kanuma address specific metabolic disorders. It differentiates itself through a deep focus on complement biology, pursuing first- or best-in-class therapies, and using a strategy that blends internal R&D with acquisitions to expand its pipeline. Its goal is to improve outcomes for patients with rare diseases and bring these therapies to a broader international market using AstraZeneca’s scale and capabilities.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Boston, MA
Founded
1992

Recently Posted Jobs

Explore more opportunities at Alexion

See more jobs